Cognitive training to improve decision-making in mid-life individuals
Remediation of Elevated Delay Discounting in Mid-life Individuals: A Stage-II Trial
This study tests whether cognitive training can help mid-life individuals who faced early-life challenges make better health decisions by improving their ability to wait for rewards.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 680 (estimated) |
| Ages | 40 Years to 60 Years |
| Sex | All |
| Sponsor | University of Kansas Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT03501706 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of cognitive improvement training on delay discounting in mid-life individuals who have experienced early-life disadvantages. It focuses on enhancing executive functioning skills to help participants make healthier decisions by reducing their preference for immediate rewards. The intervention includes various memory recall tasks designed to strengthen cognitive processes over a 5-7 week program. Participants will be evaluated on their ability to delay gratification and make better health-related choices.
Who should consider this trial
Good fit: Ideal candidates are community members from Baltimore, Maryland, who are willing to engage in a cognitive training program.
Not a fit: Patients with severe substance use disorders, significant medical or psychiatric conditions, or severe depression may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved decision-making and healthier lifestyle choices for mid-life individuals.
How similar studies have performed: Previous studies have shown promising results in improving executive function to reduce delay discounting, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Community members in neighborhoods of Baltimore, Maryland * Participants willing to participate in the 5-7 week program Exclusion Criteria: * Participants with a severe substance use disorder according to the DSM-5 with any substance other than tobacco * Participants with any significant medical or psychiatric condition which the training is not designed for (e.g., traumatic brain injury, dementia, significant learning disability, or schizophrenia) * Participants with severe depression
Where this trial is running
Baltimore, Maryland
- University of Kansas-Lawrence — Baltimore, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Richard Yi, PhD — University of Kansas
- Study coordinator: Richard Yi, PhD
- Email: ryi1@ku.edu
- Phone: 785-864-6476
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.